Literature DB >> 23179339

Gambogic acid is cytotoxic to cancer cells through inhibition of the ubiquitin-proteasome system.

Jenny Felth1, Karolina Lesiak-Mieczkowska, Padraig D'Arcy, Caroline Haglund, Joachim Gullbo, Rolf Larsson, Stig Linder, Lars Bohlin, Mårten Fryknäs, Linda Rickardson.   

Abstract

Gambogic acid (GA), displays cytotoxicity towards a wide variety of tumor cells and has been shown to affect many important cell-signaling pathways. In the present work, we investigated the mechanism of action of GA by analysis of drug-induced changes in gene expression profiles and identified GA and the derivative dihydro GA as possible inhibitors of the ubiquitin-proteasome system (UPS). Both GA and dihydro GA inhibited proteasome function in cells resulting in the accumulation of polyubiquitin complexes. In vitro experiments showed that both GA and dihydro GA inhibited 20S chymotrypsin activity and the inhibitory effects of GA and dihydro GA on proteasome function corresponded with apoptosis induction and cell death. In conclusion, our results show that GA and dihydro GA exert their cytotoxic activity through inhibition of the UPS, specifically by acting as inhibitors of the chymotrypsin activity of the 20S proteasome.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23179339     DOI: 10.1007/s10637-012-9902-y

Source DB:  PubMed          Journal:  Invest New Drugs        ISSN: 0167-6997            Impact factor:   3.850


  59 in total

1.  Gambogic acid inhibits Hsp90 and deregulates TNF-α/NF-κB in HeLa cells.

Authors:  Lianru Zhang; Yuting Yi; Junjie Chen; Yifei Sun; Qiuju Guo; Zhonghui Zheng; Siyang Song
Journal:  Biochem Biophys Res Commun       Date:  2010-11-11       Impact factor: 3.575

2.  Cytotoxic and anti-HIV-1 caged xanthones from the resin and fruits of Garcinia hanburyi.

Authors:  Vichai Reutrakul; Natthinee Anantachoke; Manat Pohmakotr; Thaworn Jaipetch; Samaisukh Sophasan; Chalobon Yoosook; Jittra Kasisit; Chanita Napaswat; Thawatchai Santisuk; Patoomratana Tuchinda
Journal:  Planta Med       Date:  2006-11-21       Impact factor: 3.352

3.  Celastrol, a novel triterpene, potentiates TNF-induced apoptosis and suppresses invasion of tumor cells by inhibiting NF-kappaB-regulated gene products and TAK1-mediated NF-kappaB activation.

Authors:  Gautam Sethi; Kwang Seok Ahn; Manoj K Pandey; Bharat B Aggarwal
Journal:  Blood       Date:  2007-04-01       Impact factor: 22.113

4.  Proteasome inhibitor induced gene expression profiles reveal overexpression of transcriptional regulators ATF3, GADD153 and MAD1.

Authors:  J Zimmermann; D Erdmann; I Lalande; R Grossenbacher; M Noorani; P Fürst
Journal:  Oncogene       Date:  2000-06-08       Impact factor: 9.867

Review 5.  Marizomib, a proteasome inhibitor for all seasons: preclinical profile and a framework for clinical trials.

Authors:  B C Potts; M X Albitar; K C Anderson; S Baritaki; C Berkers; B Bonavida; J Chandra; D Chauhan; J C Cusack; W Fenical; I M Ghobrial; M Groll; P R Jensen; K S Lam; G K Lloyd; W McBride; D J McConkey; C P Miller; S T C Neuteboom; Y Oki; H Ovaa; F Pajonk; P G Richardson; A M Roccaro; C M Sloss; M A Spear; E Valashi; A Younes; M A Palladino
Journal:  Curr Cancer Drug Targets       Date:  2011-03       Impact factor: 3.428

6.  A role for transferrin receptor in triggering apoptosis when targeted with gambogic acid.

Authors:  Shailaja Kasibhatla; Katayoun A Jessen; Sergei Maliartchouk; Jean Yu Wang; Nicole M English; John Drewe; Ling Qiu; Shannon P Archer; Anthony E Ponce; Nilantha Sirisoma; Songchun Jiang; Han-Zhong Zhang; Kurt R Gehlsen; Sui Xiong Cai; Douglas R Green; Ben Tseng
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-15       Impact factor: 11.205

7.  Gambogic acid is an antagonist of antiapoptotic Bcl-2 family proteins.

Authors:  Dayong Zhai; Chaofang Jin; Chung-Wai Shiau; Shinichi Kitada; Arnold C Satterthwait; John C Reed
Journal:  Mol Cancer Ther       Date:  2008-06       Impact factor: 6.261

8.  Microtubule depolymerization and phosphorylation of c-Jun N-terminal kinase-1 and p38 were involved in gambogic acid induced cell cycle arrest and apoptosis in human breast carcinoma MCF-7 cells.

Authors:  Jing Chen; Hong-Yan Gu; Na Lu; Yong Yang; Wei Liu; Qi Qi; Jing-Jing Rong; Xiao-Tang Wang; Qi-Dong You; Qing-Long Guo
Journal:  Life Sci       Date:  2008-05-16       Impact factor: 5.037

9.  Immunosuppressive effects of the heat shock protein 90-binding antibiotic geldanamycin.

Authors:  T Sugita; S Tanaka; T Murakami; H Miyoshi; T Ohnuki
Journal:  Biochem Mol Biol Int       Date:  1999-04

10.  Bortezomib inhibits nuclear factor-kappaB dependent survival and has potent in vivo activity in mesothelioma.

Authors:  Andrea Sartore-Bianchi; Fabio Gasparri; Arturo Galvani; Linda Nici; James W Darnowski; Dario Barbone; Dean A Fennell; Giovanni Gaudino; Camillo Porta; Luciano Mutti
Journal:  Clin Cancer Res       Date:  2007-10-01       Impact factor: 12.531

View more
  8 in total

1.  Gambogic acid moderates cardiac responses to chronic hypoxia likely by acting on the proteasome and NF-κB pathway.

Authors:  Canguo Zhao; Shouting Liu; Changshan Yang; Xiaofen Li; Hongbiao Huang; Ningning Liu; Shujue Li; Xuejun Wang; Jinbao Liu
Journal:  Am J Cardiovasc Dis       Date:  2013-08-16

2.  Inhibition of inwardly rectifying Kir2.x channels by the novel anti-cancer agent gambogic acid depends on both pore block and PIP2 interference.

Authors:  Daniel Scherer; Benedikt Schworm; Claudia Seyler; Panagiotis Xynogalos; Eberhard P Scholz; Dierk Thomas; Hugo A Katus; Edgar Zitron
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-04-02       Impact factor: 3.000

Review 3.  Molecular targets of gambogic acid in cancer: recent trends and advancements.

Authors:  Dharambir Kashyap; Rajkumar Mondal; Hardeep Singh Tuli; Gaurav Kumar; Anil K Sharma
Journal:  Tumour Biol       Date:  2016-07-22

4.  Gambogic acid suppresses pressure overload cardiac hypertrophy in rats.

Authors:  Shouting Liu; Canguo Zhao; Changshan Yang; Xiaofen Li; Hongbiao Huang; Ningning Liu; Shujue Li; Xuejun Wang; Jinbao Liu
Journal:  Am J Cardiovasc Dis       Date:  2013-11-01

5.  Gambogic acid protects LPS-induced apoptosis and inflammation in a cell model of neonatal pneumonia through the regulation of TrkA/Akt signaling pathway.

Authors:  Xu Gao; Jingya Dai; Guifang Li; Xinya Dai
Journal:  BMC Pharmacol Toxicol       Date:  2021-05-11       Impact factor: 2.483

Review 6.  Gambogic Acid as a Candidate for Cancer Therapy: A Review.

Authors:  Yuling Liu; Yingchong Chen; Longfei Lin; Hui Li
Journal:  Int J Nanomedicine       Date:  2020-12-22

Review 7.  Repurposing old drugs as new inhibitors of the ubiquitin-proteasome pathway for cancer treatment.

Authors:  Huanjie Yang; Xin Chen; Kai Li; Hassan Cheaito; Qianqian Yang; Guojun Wu; Jinbao Liu; Q Ping Dou
Journal:  Semin Cancer Biol       Date:  2019-12-26       Impact factor: 15.707

8.  Gambogic acid regulates the migration and invasion of colorectal cancer via microRNA-21-mediated activation of phosphatase and tensin homolog.

Authors:  Guangyi Gao; Yinzhu Bian; Hanqing Qian; Mi Yang; Jing Hu; Li Li; Lixia Yu; Baorui Liu; Xiaoping Qian
Journal:  Exp Ther Med       Date:  2018-07-06       Impact factor: 2.447

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.